Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Phase 1 / Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 1 / Phase 2 · 1 site
Phase 1 / Phase 2 · 1 site
Phase 2 · 1 site
Phase 1 · 1 site
Phase 3 · 18 sites
Phase 2 · 1 site
Potential match only. Final eligibility is determined by the study team.